PPBT
$3.98+0.19 (+5.05%)
Market ClosedAs of Mar 20, 8:00 PM UTC
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$3.98
Potential Upside
5%
Whystock Fair Value$4.18
Price
UndervaluedFair ValueOvervalued
Fundamentals
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that bl...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.13M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.74
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-9.92%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.78
Recent News
No recent news found.